VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Prognostic significance of PET-CT status after first line immuno-chemotherapy for FL

Judith Trotman, MBChB, FRACP, FRCPA, of the University of Sydney School of Medicine, Sydney, Australia, discusses the prognostic value of PET-CT status after long-term follow-up of follicular lymphoma (FL) patients enrolled in the GALLIUM study (NCT01332968) which aimed to evaluate the efficacy of first-line immunochemotherapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter